NCT01890486
- Conditions
- Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Blood Protein Disorders, +40 more
- Locations
-
- Wake Forest Baptist Health Winston-Salem, North Carolina, United States
Clinical trial condition
Lymphoma, Non-Hodgkin
Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.
1,630 public trials
214 recruiting studies
Lymphoma, Non-Hodgkin trial results
NCT07260812
- Conditions
- Diffuse Large B Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
- Locations
-
- Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology Wuhan, Hubei, China
- Conditions
- Agammaglobulinemia, B-cell Chronic Lymphocytic Leukemia, Bacterial Infections, +25 more
- Locations
-
- GC2202 Study Site 115 Huntington Park, California, United States
- GC2202 Study Site 103 St. Petersburg, Florida, United States
- GC2202 Study Site 111 Bethesda, Maryland, United States
- GC2202 Study Site 109 Greenville, North Carolina, United States
NCT06923397
- Conditions
- Behavior, Hemic and Lymphatic Diseases, Hodgkin Disease, +10 more
- Locations
-
- Dana Farber Cancer Institute Boston, Massachusetts, United States
NCT06208735
- Conditions
- B-cell Acute Lymphoblastic Leukemia, B-cell Leukemia, B-cell Lymphoma, +28 more
- Locations
-
- Arthur J.E. Child Comprehensive Cancer Centre Calgary, Alberta, Canada
- Alberta Children's Hospital Calgary, Alberta, Canada
- Vancouver General Hospital Vancouver, British Columbia, Canada
- BC Children's Hospital Vancouver, British Columbia, Canada
Recruiting
Single-Arm Comprehensive Ablative Bridging Irradiation I Prior to CD19 CAR-T In High-Risk R/R LBCL
NCT06104592
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- Moffitt Cancer Center Tampa, Florida, United States
NCT06533579
- Conditions
- B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, Chronic Disease, +40 more
- Locations
-
- City of Hope Duarte, California, United States
- Valkyrie Clinical Trials Los Angeles, California, United States
- Colorado Blood Cancer Institute Denver, Colorado, United States
- New York Medical College Valhalla, New York, United States
Recruiting
NexCAR19 (Talikabtagene Autoleucel) in Relapsed/Refractory B-Cell Malignancies (NexCAR19)
NCT07502118
- Conditions
- Burkitt Lymphoma, Cytokine Release Syndrome, DNA Virus Infections, +29 more
- Locations
-
- Ankara Bilkent City Hospital - Hematology Clinic Ankara, Turkey (Türkiye)
- Ankara Etlik City Hospital - Hematology Clinic Ankara, Turkey (Türkiye)
- Hacettepe University Faculty of Medicine - Department of Internal Medicine, Division of Hematology Ankara, Turkey (Türkiye)
- University of Health Sciences Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital Ankara, Turkey (Türkiye)
NCT03297606
- Conditions
- Advanced Solid Tumors, Blood Protein Disorders, Cardiovascular Diseases, +16 more
- Locations
-
- Cross Cancer Institute Edmonton, Alberta, Canada
- BCCA - Kelowna Kelowna, British Columbia, Canada
- BCCA - Vancouver Vancouver, British Columbia, Canada
- Kingston Health Sciences Centre Kingston, Ontario, Canada
NCT06915246
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +9 more
- Locations
-
- City of Hope Phoenix Goodyear, Arizona, United States
- City of Hope National Medical Center Duarte, California, United States
- City of Hope Atlanta Newnan, Georgia, United States
- City of Hope Chicago Zion, Illinois, United States